Evidence-Based Complementary and Alternative Medicine / 2016 / Article / Tab 1 / Research Article
Complementary and Alternative Medicine Use and Its Association with Quality of Life among Cancer Patients Receiving Chemotherapy in Ethiopia: A Cross-Sectional Study Table 1 Sociodemographic and clinical characteristics of CAM users and non-CAM users.
Variables CAM users (%) Non-CAM users (%) Multivariate logistic regression Age 0.754 18–29 19 (12.3%) 5 (12.2%) — 30–39 44 (28.6%) 7 (17.1%) — 40–49 56 (36.4%) 18 (43.9%) — 50–59 20 (13%) 5 (12.2%) — 60+ 15 (9.7%) 6 (14.6%) — Sex 0.300 Male 72 (46.8%) 17 (41.5%) — Female 82 (53.2%) 24 (58.5%) — Educational status <0.001 Primary 28 (18.2%) 50 (32.5%) 1 Secondary 76 (49.3%) 77 (50%) 1.35 (0.90–2.29) Tertiary 50 (32.5%) 27 (17.5%) 2.73 (1.27–4.78) Marital status Single 26 (16.9%) 8 (19.5%) 0.632 — Ever married 128 (83.1%) 33 (80.5%) — Average monthly income <125 USD 109 (70.8%) 35 (85.4%) 0.001 1 >125 USD 45 (29.2%) 6 (14%) 5.12 (1.82–6.05) Employment status 0.162 Unemployed 108 (70.1%) 30 (73.2%) 1 Employed 46 (29.9%) 11 (26.8%) 0.89 (0.51–1.51) Religion 0.347 Orthodox 68 (44.1%) 7 (17.1%) — Muslim 39 (25.3%) 8 (19.5%) — Protestant 21 (13.6%) 10 (24.4%) — Catholic 19 (12.3%) 12 (29.3%) — Others 7 (4.5%) 4 (9.7%) — Cancer type 0.584 Hematologic malignancies 50 (32.5%) 11 (26%) — Breast cancer 56 (36.4%) 18 (43.9%) — Gastrointestinal malignancies1 18 (11.7%) 4 (9.7%) — Gynecologic2 malignancies 18 (11.7%) 6 (14.6%) — Others 12 (7.8%) 2 (4.9%) — Duration of cancer 0.132 <1 year 65 (42.2%) 15 (36.6%) 1 1–5 year 55 (35.7%) 16 (39%) 0.70 (0.35–1.38) >5 year 36 (23.4%) 10 (24.4%) 0.80 (0.37–1.72) Stage of disease 0.013 Early 94 (61%) 29 (70.7%) 1 Advanced 60 (39%) 12 (29.3%) 2.85 (1.73–2.93) Treatment modality 0.300 Chemotherapy 89 (57.8%) 32 (78%) — Surgery 35 (22.7%) 5 (12.2%) — Both 30 (19.5%) 4 (9.7%) — Chemotherapy cycle 0.584 <4 106 (68.8%) 29 (70.7%) — >4 48 (31.2%) 12 (29.3%) — Comorbidity 0.020 No 52 (33.8%) 29 (70.7%) 1 Yes 102 (66.2%) 12 (29.3%) 3.71 (1.97–6.53)
